This page is part of the Adverse Event Clinical Research R4 Backport (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Generated Narrative: AdverseEvent
Resource AdverseEvent "adverse-event-compass-ex1a"
Profile: Adverse Event Clinical Research
Resulting Effect: : Reference to Observation of Alanine aminotransferase (ALT) increased at 200
Supporting information relevant to the event
url
item
value: : Supporting info would have context such as an Reference to Observation of Alanine aminotransferase (ALT) increased at 200
Adverse Event Grade: Grade 3 Severe Adverse Event (NCI Thesaurus#C41340)
Participant
url
function
value: authenticator (ParticipationType#AUTHEN)
url
actor
value: Practitioner/practitioner-owen-oncologist " ONCOLOGIST"
Suspect Entity
url
instance
value: MedicationAdministration/medication-administration-kadcyla
url
causality
Suspect Entity
url
instance
value: MedicationAdministration/medication-administration-tucatinib
url
causality
Expected In Research Study: true
Note: treatment held today per protocol guidelines and the patient was scheduled to return in one week for repeat lab work
modifierExtension[http://hl7.org/fhir/uv/ae-research-backport-ig/StructureDefinition/status]
actuality: actual
event: Alanine aminotransferase (ALT) increased to 200 (Medical Dictionary for Regulatory Activities#10001551 "Alanine aminotransferase increased")
subject: Patient/patient-example-kaitlyn-b " BOUNCE"
date: 2020-05-13
seriousness: Non-serious (AdverseEventSeriousness#non-serious)
outcome: Not recovering/not resolved (NCI Thesaurus#C49494)
recorder: Practitioner/practitioner-oncology-nurse-jane " NURSE"